News

Argent BioPharma has started formal clinical supply of its EU-GMP cannabinoid-based active pharmaceutical ingredient (API) ...
SNS Insider Reveals U.S. Pyrogen Testing Market Valued at USD 0.46 Billion in 2023, Poised to Hit USD 0.85 Billion by 2032 Amid Rising Biologics Pipeline, GMP Compliance, and Demand for Endotoxin-Free ...
The "Cybersecurity - The Latest US FDA Requirements" webinar has been added to ResearchAndMarkets.com's offering.This live training webinar includes the following for each registered attendee: A copy ...
Milestone Pharmaceuticals Inc. is a strong buy under $2 with FDA approval for Cardamyst expected in 2026, offering unique ...
WuXi XDC announces the mechanical completion of its Singapore site, accelerating the global expansion of bioconjugates manufacturing: Shanghai, China Wednesday, July 2, 2025, 11:0 ...
Published on June 18, 2024, this rule revises requirements around current good manufacturing practice (CGMP), post-marketing ...
New Zealand is one of the best places in the world to grow dope, but producing marketable medicinal cannabis is a regulatory ...
Abinopharm, Inc., an innovative nutritional and biopharmaceutical company based in Shelton, Connecticut, USA, is pleased to ...
Karnataka: Shilpa Medicare Limited's 100 percent subsidiary, Shilpa Pharma Lifesciences Limited, Unit-1 has successfully ...
CPHI China has long been recognized as a premier platform for connecting the entire pharmaceutical supply chain, from active ...
The global cell culture media market, valued at $5.2 billion in 2023, is projected to surge to $17.6 billion by 2035, growing at a CAGR of 10.7% from 2024 to 2035. This exponential growth is fueled by ...